?
Zakrowski Donald A
SVP, Finance, & CAO
Eli Lilly and Company
US, Indianapolis [HQ]
CIK
1561539
Data Source
We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.
Latest Information
Shares :
8,630
Price per Share :
$725.72
Equivalence :
$6,262,963.60
Transaction History
-
A8,630 Shares After TransactionValue : $6,362,553.80$924,524.04Transaction Date : 02/12/24
-
Footnotes
-
-
Footnotes:No footnote found.
-
S6,380 Shares After TransactionValue : $6,061,000.00Sold $712,500.00Transaction Date : 08/26/24
-
Footnotes
-
-
Footnotes:#1 The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2023.
-
S7,130 Shares After TransactionValue : $5,842,821.10Sold $614,602.50Transaction Date : 06/03/24
-
Footnotes
-
-
Footnotes:#1 The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2023.
-
S7,880 Shares After TransactionValue : $5,938,368.00Sold $565,200.00Transaction Date : 03/11/24
-
Footnotes
-
-
Footnotes:#1 The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2023.
-
S5,480 Shares After TransactionValue : $4,402,522.40Sold $723,042.00Transaction Date : 11/08/24
-
Footnotes
-
-
Footnotes:#1 The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2023.